Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Category: Uncategorized

Eye Complications in People With Diabetes: Silent, Progressive, but Preventable

23/10/2026 Published by HealthBiz

Vision in people with diabetes can decline without warning. In its early stages, diabetic retinopathy usually causes no pain and... Read more

Tags: #Personal Health

Acute Asthma Attack at the Office: How Can Colleagues Help?

23/10/2026 Published by HealthBiz

An ordinary afternoon at the office: the coworker next to you starts coughing and wheezing, clutches their chest, and can't... Read more

Category: Uncategorized

Tags: #Corporate Wellness

The situational architecture of elite performance: Beyond innate willpower

23/10/2026 Published by HealthBiz

Within strategic human capital management and executive development—particularly across high-stakes domains such as healthcare systems and biotechnology—grit (conceptualized as the... Read more

Category: Uncategorized

Tags: #Human Resources

Navigating the AI marketing J-curve: From operational friction to compounding growth

23/10/2026 Published by HealthBiz

1. The productivity paradox and the reality of initial complexity Chief Marketing Officers (CMOs) embarking on algorithmic organizational redesign frequently... Read more

Category: Uncategorized

Tags: #Capability Development

ASTELLAS SIGNS $400M-PLUS AI PROTEIN DISCOVERY DEAL: WHY PHARMA IS MOVING FROM FINDING MOLECULES TO ENGINEERING MEDICINES BY DESIGN

22/10/2026 Published by HealthBiz

Key Development Astellas Pharma has entered a research collaboration and licensing agreement with Boston-based AI Proteins, with potential payments exceeding... Read more

Category: Uncategorized

Tags: #Global Trends

ASTRAZENECA–AMGEN’S TEZSPIRE ACHIEVES 69% REMISSION IN ESOPHAGEAL DISEASE: WHY MULTI-INDICATION BIOLOGICS ARE RESHAPING THE IMMUNOLOGY MARKET

21/10/2026 Published by HealthBiz

Key Development AstraZeneca and Amgen have reported full Phase III CROSSING trial results showing that Tezspire (tezepelumab), an established biologic... Read more

Category: Uncategorized

Tags: #Global Trends

ROCHE ADVANCES THREE ONCOLOGY PLATFORMS AT ESMO 2026: WHY THE NEXT CANCER DRUG BATTLE IS ABOUT CLINICAL DIFFERENTIATION, NOT PIPELINE SIZE

21/10/2026 Published by HealthBiz

Key Development Roche is preparing to present pivotal oncology data at the European Society for Medical Oncology (ESMO) Congress 2026,... Read more

Category: Uncategorized

Tags: #Global Trends

HIMS & HERS EXPANDS WEIGHT MANAGEMENT INTO GERMANY: WHY TELEHEALTH IS RESHAPING THE COMMERCIAL VALUE CHAIN OF OBESITY TREATMENT

21/10/2026 Published by HealthBiz

Key Development Hims & Hers Health has launched an online weight-management service for men in Germany, extending its European presence... Read more

Category: Uncategorized

Tags: #Global Trends

NOVO NORDISK’S CAGR ISEMA DELIVERS 25% WEIGHT LOSS IN WOMEN: WHY THE NEXT OBESITY DRUG BATTLE WILL BE FOUGHT OVER CLINICAL DIFFERENTIATION, NOT HEADLINE EFFICACY

21/10/2026 Published by HealthBiz

Key Development Novo Nordisk has reported new Phase 3 subgroup analyses showing that its investigational combination therapy CagriSema was associated... Read more

Category: Uncategorized

Tags: #Global Trends

Posts pagination

Page 1 Page 2 … Page 224 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members